|
3
|
|
Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis.
(journals.asm.org)
|
Alshehri A
…
Murry DJ
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#modeling
#parasitic
#antiparasitic
#lymphatic
|
|
3
|
|
Development and validation of a cefepime population pharmacokinetic model to guide treatment for patients with hospital-acquired pneumonia requiring renal replacement.
(journals.asm.org)
|
Valadez A
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#pneumonia
#renal replacement therapy
#modeling
#antibiotic
|
|
3
|
|
Modeling the potential effect of cabamiquine-pyronaridine for chemoprevention against Plasmodium falciparum malaria.
(journals.asm.org)
|
Okell LC
…
Okebe J
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#malaria
#chemoprevention
#pharmacokinetics
#modeling
#amr
|
|
3
|
|
Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV.
(journals.asm.org)
|
Nussbaum JC
…
Gillespie G
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#hiv
#drug-interactions
#clinical trial
|
|
2
|
|
Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid fever.
(academic.oup.com)
|
Bakthavatchalam YD
…
Veeraraghavan B
Journal of Antimicrobial Chemotherapy
2026-10-06
|
#typhoid
#pharmacokinetics
#amr
#antibiotic
|
|
2
|
|
Microbial aldehyde-alcohol dehydrogenase degrades metformin to limit therapeutic response in type 2 diabetes.
(linkinghub.elsevier.com)
|
Zhao Y
…
Wang T
Cell Metabolism
2026-09-29
|
#microbiome
#diabetes
#pharmacokinetics
#metabolism
#enzyme
|
|
1
|
|
Vancomycin treatment outcomes and machine learning-based identification of heterogeneous vancomycin-intermediate Staphylococcus aureus infections.
(linkinghub.elsevier.com)
|
Fan Y
…
Zhang J
International Journal of Antimicrobial Agents
2026-10-05
|
#amr
#antibiotic
#pharmacokinetics
#machine learning
#infection
|
|
1
|
|
A single-dose topical therapy cures scabies in a human-relevant porcine model.
(science.org)
|
Fernando DD
…
Fischer K
Science Translational Medicine
2026-09-30
|
#scabies
#parasiticide
#amr
#pharmacokinetics
|
|
1
|
|
Soft drugs: design principles and topical applications.
(nature.com)
|
Pirali T
…
Carzaniga L
Nature Reviews Drug Discovery
2026-09-30
|
#pharmacokinetics
#drug design
#metabolism
#toxicity
|
|
1
|
|
Clinical trials in a dish: cardiometabolic drug development with biological and digital twins.
(jci.org)
|
Patra D
…
Wu JC
Journal of Clinical Investigation
2026-10-01
|
#cardiotoxicity
#preclinical
#pharmacokinetics
#organoid
#modeling
|
|
0
|
|
Pulmonary pharmacokinetics and lesion penetration of antimicrobials in patients with nontuberculous mycobacterial disease.
(journals.asm.org)
|
Watanabe F
…
Morimoto K
Antimicrobial Agents and Chemotherapy
2026-10-01
|
#pharmacokinetics
#mycobacterial
#pulmonary
#antimicrobial-therapy
#dosing
|
|
0
|
|
Association between Beta-Lactam concentration and Liver Injury in Critically Ill Patients.
(linkinghub.elsevier.com)
|
Farinella A
…
Bogossian EG
International Journal of Antimicrobial Agents
2026-09-30
|
#pharmacokinetics
#antibiotic
#toxicity
#hepatotoxicity
#icu
|
|
0
|
|
Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.
(academic.oup.com)
|
Alkhafaji S
…
Savic RM
Journal of Infectious Diseases
2026-09-30
|
#pharmacokinetics
#tb
#pharmacodynamics
#dosing
#antibiotic
|
|
0
|
|
A Phase I, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, and pharmacokinetics of intravenous ertapenem and zidebactam in combination (WCK 6777) in healthy adult subjects.
(journals.asm.org)
|
Lodise TP
…
Bonomo RA
Antimicrobial Agents and Chemotherapy
2026-09-29
|
#pharmacokinetics
#clinical trial
#antibiotic
#amr
|
|
0
|
|
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients With Complicated Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics (dagger).
(academic.oup.com)
|
Miller LG
…
Peck MC
Open Forum Infectious Diseases
2026-10-01
|
#clinical trial
#bacteremia
#pharmacokinetics
#amr
#immunotherapy
|